Rare diseases
Investigational molecules
Locations
1 Horizon Way, 60015-3888, United States
Horizon Therapeutics USA Inc. focuses on clinical research in thyroid eye disease, with attention to both moderate-to-severe active thyroid eye disease and broader disease management in adult patients.
The sponsor’s studies center on outcomes relevant to eye prominence, symptom control, and disease activity in this autoimmune condition.
Horizon Therapeutics USA Inc. runs clinical trials in conditions such as Endocrine ophthalmopathy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
